Moderna
MRNA
#1328
Rank
C$19.44 B
Marketcap
$50.53
Share price
5.34%
Change (1 day)
-57.25%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -C$3.18 Billion

According to Moderna 's latest financial reports the company's current earnings are C$5.05 Billion. In 2023 the company made an earning of -C$5.56 Billion a decrease over its 2022 earnings that were of C$13.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$3.18 Billion-42.81%
2023 -C$5.56 Billion-140.65%
2022 C$13.65 B-27.81%
2021 C$18.92 B-1911.15%
2020 -C$1.05 Billion44.7%
2019 -C$0.73 Billion28.63%
2018 -C$0.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$58.84 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
C$21.29 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$59.4 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.34 Billion-89.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.40 B-685.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-C$0.86 Billion-74.23%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.80 B-848.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.17 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA